Issue Date | Title | Author(s) |
2015 | Characterization of the retinal pigment epithelium in Friedreich ataxia | Crombie, DE; Van Bergen, N; Davidson, KC; Anjomani Virmouni, S; Mckelvie, PA; Chrysostomou, V; Conquest, A; Corben, LA; Pook, MA; Kulkarni, T; Trounce, IA; Pera, MF; Delatycki, MB; Pébay, A |
8-Jan-2018 | Effect of diazoxide on Friedreich ataxia models | Santoro, A; Virmouni, SA; Paradies, E; Coa, VLV; Al-Mahdawi, S; Khoo, M; Porcelli, V; Vozza, A; Perrone, M; Denora, N; Taroni, F; Merla, G; Palmieri, L; Pook, MA; Marobbio, CMT |
2014 | The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseases | Al-Mahdawi, S; Virmouni, SA; Pook, MA |
2014 | Epigenetic-based therapies for Friedreich ataxia | Sandi, C; Sandi, M; Virmouni, SA; Al-Mahdawi, S; Pook, MA |
21-Nov-2018 | FAST-1 antisense RNA epigenetically alters FXN expression | Pook, M; Mikaeili, H; Sandi, M; Bayot, A; Al-Mahdawi, S |
2007 | The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues | Pook, MA; Al-Mahdawi, S; Mouro Pinto, R; Sandi, C; Trabzuni, D |
2006 | GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology | Pook, MA; Al-Mahdawi, S; Mouro Pinto, R |
2006 | The GAA triplet-repeat is unstable in the context of the human FXN locus and displays age-dependent expansions in cerebellum and DRG in a transgenic mouse model | Pook, MA; Clark, RM; De Biase, I; Al-Mahdawi, S; Malykhina, AP; Bidichandani, S |
2013 | Genotype and phenotype characterisation of Friedreich ataxia mouse models and cells | Anjomani Virmouni, Sara |
5-Jun-2020 | HMTase Inhibitors as a Potential Epigenetic-based Therapeutic Approach for Friedreich’s Ataxia | Sherzai, M; Valle, A; Perry, N; Kalef-Ezra, E; Al-Mahdawi, S; Pook, M; Anjomani-Virmouni, S |
1-May-2015 | Identification of telomere dysfunction in Friedreich ataxia | Anjomani-Virmouni, S; Al-Mahdawi, S; Sandi, C; Yasaei, H; Slijepcevic, P; Pook, M |
10-Jun-2015 | Identification of telomere dysfunction in Friedreich ataxia. | Anjomani-Virmouni, S; Al-Mahdawi, S; Sandi, C; Yasaei, H; Giunti, P; Slijepcevic, P; Pook, M |
2012 | Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model | Tomassini, B; Arcuri, G; Fortuni, S; Sandi, C; Ezzatizadeh, V; Casali, C; Condò, I; Malisan, F; Al-Mahdawi, S; Pook, M; Testi, R |
2010 | Investigating the pathogenesis and therapy of Friedreich Ataxia | Sandi, Chiranjeevi |
2012 | The mismatch repair system protects against intergenerational GAA repeat instability in a Friedreich ataxia mouse model | Ezzatizadeh, V; Pinto, RM; Sandi, C; Sandi, M; Al-Mahdawi, S; Te Riele, H; Pook, MA |
2013 | Pharmacological screening using an FXN-EGFP cellular genomic reporter assay for the therapy of Friedreich ataxia | Li, L; Voullaire, L; Sandi, C; Pook, MA; Ioannou, PA; Delatycki, MB; Sarsero, JP |
2011 | Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model | Sandi, C; Pinto, RM; Al-Mahdawi, S; Ezzatizadeh, V; Barnes, G; Jones, S; Rusche, JR; Gottesfeld, JM; Pook, MA |
2007 | Somatic instability of the expanded GAA triplet-repeat sequence in Friedreich ataxia progresses throughout life | Pook, M A; De Biase, I; Ramussen, A; Monticelli, A; Al-Mahdawi, S; Cocozza, S; Bidichandani, S |